Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03929120 · ClinicalTrials.gov registry record · Phase 1
Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)
A Phase 1 study of Interstitial Lung Disease and Connective Tissue Diseases, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03929120: Completed Phase 1 study of Interstitial Lung Disease and Connective Tissue Diseases, sponsored by Mayo Clinic.
NCT03929120 is a Phase 1 study of Interstitial Lung Disease and Connective Tissue Diseases that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 566-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03929120, a Phase 1 study of Interstitial Lung Disease and Connective Tissue Diseases, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to find out more about the safety of a new treatment, Allogeneic (coming from a healthy donor) Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs) which is still experimental, for Interstitial Lung Disease (ILD) associated with Connective Tissue Disorder (CTD).
Primary Outcome
Number of adverse events reported with infusion of each intravenous Mesenchymal Stem Cells (MSC) dose
Conditions Studied
Interventions
- BIOLOGICAL Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-11-05 |
| Est. Completion | 2022-02-02 |
| Phase | Phase 1 |
What the finished NCT03929120 record still lists
NCT03929120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 566-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Interstitial Lung Disease appearing as the primary indexed condition, and to 1 intervention - of which Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs) is the first listed.
NCT03929120 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03929120 about?
NCT03929120 is a clinical study titled "Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)". Researchers are trying to find out more about the safety of a new treatment, Allogeneic (coming from a healthy donor) Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs) which is still experimental, for Interstitial Lung Disease (ILD) associated with Connective Tissue Disorder (CTD).
What is the current status of trial NCT03929120?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-11-05. Estimated completion is 2022-02-02.
What conditions does trial NCT03929120 study?
This clinical trial studies the following conditions: Interstitial Lung Disease, Connective Tissue Diseases.
What interventions are being tested in trial NCT03929120?
The interventions under investigation include: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03929120?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03929120 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03929120's enrollment target sits among peer trials
10 35th of 36 higher than 2 of 36 other Interstitial Lung Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Lung Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
Feasibility of Semaglutide in Advanced Lung Disease
RECRUITING · Phase 1
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
RECRUITING · Phase 2
-
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RECRUITING · Phase 3
-
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI